Skip to main content
Sami Ibrahimi, MD, Oncology, Oklahoma City, OK

Sami Ibrahimi MD

Hematologic Oncology


Physician

Join to View Full Profile
  • 800 NE 10th StStephenson Cancer CenterOklahoma City, OK 73104

  • Phone+1 405-271-4022

Dr. Ibrahimi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Oklahoma Health Sciences Center
    University of Oklahoma Health Sciences CenterFellowship, Hematology and Medical Oncology, 2015 - 2018
  • UMass Chan - Baystate
    UMass Chan - BaystateResidency, Internal Medicine, 2012 - 2015
  • University of Jordan Faculty of Medicine
    University of Jordan Faculty of MedicineClass of 2010

Certifications & Licensure

  • OK State Medical License
    OK State Medical License 2015 - 2025
  • MA State Medical License
    MA State Medical License 2012 - 2015
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Paradoxical Effects of Obesity on T Cell Function During Tumor Progression and PD-1 Checkpoint Blockade  
    R Rivkah Isseroff, Emanual Maverakis, Robert J Canter, Kurt A Schalper, Karen Kelly, Bruce R Blazar, Catherine T Le, Dan L Longo, Arta M Monjazeb, Sami Ibrahimi, Nature

Lectures

  • Role of Somatic Mutations and Clonal Thrombopoiesis in Immune Thrombocytopenia 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Thrombocytopenia Is a Biomarker for Response in Patients Treated with Anti PD-1/Pdl-1 Therapy 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Study from OU Medicine Shows Why Obese Patients Respond Better to Immunotherapy
    Study from OU Medicine Shows Why Obese Patients Respond Better to ImmunotherapyDecember 5th, 2018

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: